(Q43756712)

English

Recombinant urate oxidase (rasburicase) in the prevention and treatment of malignancy-associated hyperuricemia in pediatric and adult patients: results of a compassionate-use trial

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

Recombinant urate oxidase (rasburicase) in the prevention and treatment of malignancy-associated hyperuricemia in pediatric and adult patients: results of a compassionate-use trial (English)

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

0 references

author name string

Pui CH

1

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

Jeha S

2

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

Irwin D

3

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

Camitta B

4

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

publication date

1 October 2001

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

15

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

10

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

1505-1509

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

https://scigraph.springernature.com/pub.10.1038/sj.leu.2402235

0 references

Tumor lysis syndrome: pathogenesis and management

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402235

7 January 2021

based on heuristic

inferred from DOI database lookup

PREVENTION OF HYPERURICEMIA IN LEUKEMIA AND LYMPHOMA: USE OF ALOPURINOL, A XANTHINE OXIDASE INHIBITOR.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402235

7 January 2021

based on heuristic

inferred from DOI database lookup

Use of allopurinol for prevention and control of hyperuricemia in patients with neoplastic disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402235

7 January 2021

based on heuristic

inferred from DOI database lookup

Urinary Xanthine Stones-a Rare Complication of Allopurinol Therapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402235

7 January 2021

based on heuristic

inferred from DOI database lookup

Xanthine nephropathy in a patient with lymphosarcoma treated with allopurinol

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402235

7 January 2021

based on heuristic

inferred from DOI database lookup

Urate oxidase in prevention and treatment of hyperuricemia associated with lymphoid malignancies

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402235

7 January 2021

based on heuristic

inferred from DOI database lookup

Recombinant urate oxidase for the prophylaxis or treatment of hyperuricemia in patients With leukemia or lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402235

7 January 2021

based on heuristic

inferred from DOI database lookup

A randomized comparison between rasburicase and allopurinol in children with lymphoma or leukemia at high risk for tumor lysis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402235

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/SJ.LEU.2402235

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43756712&oldid=2103074032"